Christine Huang
Consultor / Asesor en LongeVC .
Perfil
Dr. Christine Yuan Huang is a scientific-physician and biotech entrepreneur.
She is dedicated to transitioning laboratory technologies to clinical applications to assist patients with serious illnesses.
She brings her specialized expertise to her role as an advisor at LongeVC.
Selected for Forbes China's "30 Under 30" in Healthcare and Science in 2020, Dr. Huang is a biomedicine investment consultant for China Internet Investment Finance Holding Limited.
She's a Fellow of The Royal Society of Medicine (UK) and is on the Advisory Board for Wing Wah Charity Foundation Hong Kong.
Dr. Huang is the Technology Transfer Director at Hong Kong Quantum AI Lab (the University of Hong Kong and California Institute of Technology joint R&D infrastructure), Managing Director of HK Longevity Medical Center, and Venture Partner at LongeVC.
She's also a Senior Research Associate at the University of Hong Kong and was recently elected as a Fellow of the Guangzhou Youth Federation in 2022.
Dr. Huang graduated from Southern Medical University with degrees in Medicine and Science.
She later earned a Master's degree from the Li Ka Shing Faculty of Medicine at the University of Hong Kong and trained in Neurology at Queen Mary Hospital, Hong Kong.
Cargos activos de Christine Huang
Empresas | Cargo | Inicio |
---|---|---|
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | Consultor / Asesor | - |
Antiguos cargos conocidos de Christine Huang.
Empresas | Cargo | Fin |
---|---|---|
CHINA CASTSON 81 FINANCE COMPANY LIMITED | Corporate Officer/Principal | 30/09/2023 |
Cellomics International Ltd.
Cellomics International Ltd. Miscellaneous Commercial ServicesCommercial Services Cellomics International Ltd. is a Chinese biotechnology company that focuses on developing and commercializing liquid biopsy products and services. The company is based in Hong Kong, Hong Kong. Cellomics International was founded by Christine Huang and Edwin Yu, with Christine Huang serving as the CEO since incorporation. | Director de Operaciones | 01/05/2022 |
City University of Hong Kong | Corporate Officer/Principal | 01/07/2020 |
Bacmuno Biotechnology Ltd.
Bacmuno Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Bacmuno Biotechnology Ltd. provides bacteria-based immunotherapies against cancer. It applies Salmonella genetic modification technology to cancer immunotherapy in animals and humans. The company was founded on January 23, 2017 and is headquartered in Hong Kong. | Fundador | 01/06/2019 |
Queen Mary Hospital
Queen Mary Hospital Hospital/Nursing ManagementHealth Services Queen Mary Hospital operates general medical hospitals. The private company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Yau Fun Lau. | Corporate Officer/Principal | 31/12/2017 |
Formación de Christine Huang.
Southern Medical University | Undergraduate Degree |
University of Hong Kong | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CHINA CASTSON 81 FINANCE COMPANY LIMITED | Finance |
Empresas privadas | 4 |
---|---|
Queen Mary Hospital
Queen Mary Hospital Hospital/Nursing ManagementHealth Services Queen Mary Hospital operates general medical hospitals. The private company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Yau Fun Lau. | Health Services |
Bacmuno Biotechnology Ltd.
Bacmuno Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Bacmuno Biotechnology Ltd. provides bacteria-based immunotherapies against cancer. It applies Salmonella genetic modification technology to cancer immunotherapy in animals and humans. The company was founded on January 23, 2017 and is headquartered in Hong Kong. | Health Technology |
Cellomics International Ltd.
Cellomics International Ltd. Miscellaneous Commercial ServicesCommercial Services Cellomics International Ltd. is a Chinese biotechnology company that focuses on developing and commercializing liquid biopsy products and services. The company is based in Hong Kong, Hong Kong. Cellomics International was founded by Christine Huang and Edwin Yu, with Christine Huang serving as the CEO since incorporation. | Commercial Services |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | Finance |
- Bolsa de valores
- Insiders
- Christine Huang